This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Explore the proven benefits of zero based budgeting and how it creates accountability and tangible financial outcomes.
22,288 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
U.S. prosecutors allege a scheme to move Nvidia GPUs and servers to China, with Supermicro’s co-founders at the cente...
A new Ripple survey shows banks leaning into digital assets, with stablecoins leading cash-flow efficiency. For XRP, ...
IonQ faces a pivotal year as government and enterprise demand grows for quantum hardware and software. Analysts outli...
TD Cowen warns that bills advancing prediction markets face a tough path in Congress this year, citing bipartisan con...
XRP’s Bollinger Bands have tightened once more, reviving chatter of a possible breakout. Here’s what traders are watc...
Morgan Stanley reports record revenue for 2025 and a solid Q4, but shares fall as liquidity constraints in private ma...
Investors are weighing whether HOOD deserves a place in a modern portfolio. This guide helps you gauge signals, risks...
Two popular consumer staples ETFs—FSTA and FTXG—offer different routes to defense in a volatile market. This guide br...
The Fundrise VCX fund, once a magnet for IPO-obsessed investors, dropped 45% from its peak as market enthusiasm for p...
A viral parody drawing 110 million views isn’t just a pop culture moment—it also tests money decisions. This guide sh...
Cybersecurity stocks tumbled as Anthropic rolled out a new AI model, sending Palo Alto Networks and other peers lower...